|
Parkinson's Disease Clinical Trials in Memphis, TN
2 recruiting studies within 50 miles
Phase
| Trial | Phase | Dist. |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | Phase 3 | <1 mi |
| A Study of Buntanetap in Participants With PD | Phase 2/3 | <1 mi |
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.